Juan Zhang

Songhu Road 2005
Yangpu, 200433, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications

Efficacy of Locoregional HAIC and Systemic Treatment for Treatment- Naive Unresectable Hepatocellulcar Carcinoma.

Efficacy of Locoregional HAIC and Systemic Treatment for Treatment- Naive Unresectable Hepatocellulcar Carcinoma.

Journal: Journal of hepatocellular carcinoma
Published: March 03, 2026

Spontaneous rupture of hepatic metastasis as the initial presentation of gastric hepatoid adenocarcinoma: a rare case report and literature review.

Spontaneous rupture of hepatic metastasis as the initial presentation of gastric hepatoid adenocarcinoma: a rare case report and literature review.

Journal: Frontiers in oncology
Published: November 17, 2025

Robust transcriptomic hallmarks targeting intratumor heterogeneity in intrahepatic cholangiocarcinoma.

Robust transcriptomic hallmarks targeting intratumor heterogeneity in intrahepatic cholangiocarcinoma.

Journal: Cell reports. Medicine
Published: July 18, 2025

HKI-357 inhibits castration-resistant prostate cancer by targeting UBE2C via the AKT signaling pathway.

HKI-357 inhibits castration-resistant prostate cancer by targeting UBE2C via the AKT signaling pathway.

Journal: Biochemical pharmacology
Published: June 15, 2025

Prognostic Value of Gd-BOPTA Enhanced MRI in Solitary Resected Hepatocellular Carcinoma Without Microvascular Invasion.

Prognostic Value of Gd-BOPTA Enhanced MRI in Solitary Resected Hepatocellular Carcinoma Without Microvascular Invasion.

Journal: Journal of hepatocellular carcinoma
Published: April 09, 2025

A Refined Prognostic Model for Postoperative Overall Survival in Hepatocellular Carcinoma Based on CODEX-Based Multiproteomics and Radiomics.

A Refined Prognostic Model for Postoperative Overall Survival in Hepatocellular Carcinoma Based on CODEX-Based Multiproteomics and Radiomics.

Journal: Journal of hepatocellular carcinoma
Published: March 09, 2025

Intratumoral and Peritumoral Radiomics Based on DCE-MRI for Prediction of Microvascular Invasion Grading in Solitary Hepatocellular Carcinoma (≤3 cm).

Intratumoral and Peritumoral Radiomics Based on DCE-MRI for Prediction of Microvascular Invasion Grading in Solitary Hepatocellular Carcinoma (≤3 cm).

Journal: Journal of hepatocellular carcinoma
Published: February 13, 2025

Efficacy of transcatheter arterial chemoembolization-based multimodal treatment in patients with neuroendocrine tumors involving the liver.

Efficacy of transcatheter arterial chemoembolization-based multimodal treatment in patients with neuroendocrine tumors involving the liver.

Journal: Translational cancer research
Published: December 08, 2024

CAD manipulates tumor intrinsic DHO/UBE4B/NF-κB pathway and fuels macrophage cross-talk, promoting HCC metastasis.

CAD manipulates tumor intrinsic DHO/UBE4B/NF-κB pathway and fuels macrophage cross-talk, promoting HCC metastasis.

Journal: Hepatology (Baltimore, Md.)
Published: October 23, 2024

Discovery of a novel BCL-2 inhibitor GW806742X for the treatment of TNBC.

Discovery of a novel BCL-2 inhibitor GW806742X for the treatment of TNBC.

Journal: Biochemical pharmacology
Published: October 16, 2024

AGEs-RAGE manipulates tumor intrinsic pERK/Sp1/IL6 pathway and reprograms macrophage to promote intrahepatic cholangiocarcinoma progression.

AGEs-RAGE manipulates tumor intrinsic pERK/Sp1/IL6 pathway and reprograms macrophage to promote intrahepatic cholangiocarcinoma progression.

Journal: Translational oncology
Published: June 28, 2024

Prediction of Microvascular Invasion and Recurrence After Curative Resection of LI-RADS Category 5 Hepatocellular Carcinoma on Gd-BOPTA Enhanced MRI.

Prediction of Microvascular Invasion and Recurrence After Curative Resection of LI-RADS Category 5 Hepatocellular Carcinoma on Gd-BOPTA Enhanced MRI.

Journal: Journal of hepatocellular carcinoma
Published: March 19, 2024
Showing 1-12 of 50

Last Updated: 09/26/2026